|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| General and administrative | |||||
| Amortization and depreciation | |||||
| Depreciation | |||||
| Research and development | |||||
| Legal Settlement Loss | |||||
| Total operating expenses | |||||
| Operating (loss) gain | |||||
| Interest and other income (expense): | |||||
| Interest income | |||||
| Interest on convertible notes | |||||
| Amortization of discount on convertible notes | |||||
| Amortization of debt issuance costs | |||||
| Loss on note extinguishment | |||||
| Standby equity purchase agreement commitment fee | |||||
| Issuance costs for private placement of shares and warrants through placement agent | |||||
| Legal settlement revaluation | |||||
| Loss on induced conversion | |||||
| Finance charges | |||||
| Gain on restructuring of payables | |||||
| Total interest and other expenses | |||||
| Total interest and other income (expense) | |||||
| Loss on derivatives | |||||
| Total interest and other expense | |||||
| (Loss) gain before income taxes | |||||
| Income tax benefit | |||||
| Net (loss) income | |||||
| (Loss) income per share: | |||||
| Basic (loss) income per share | |||||
| Diluted (loss) income per share | |||||
| Weighted average common shares used in calculation of (loss) income per share: | |||||
| Weighted average common shares outstanding, Basic | |||||
| Weighted average common shares outstanding, Diluted | |||||
Loading...